The invention relates to the technical field of medicines and in particular relates to a hand-foot-and-mouth
disease resistant
drug activity detection method and kit. The detection method comprises the following steps: inserting a
nucleotide sequence encoding Gln-Gly into a
luciferase plasmid, thereby obtaining recombinant
luciferase containing Gln-Gly by virtue of in-vitro acellular transcription and translation; performing in-vitro
recombinant expression on hand-foot-and-mouth
virus protease, wherein the hand-foot-and-mouth
virus protease refers to 2A or 3C
protease; carrying out an enzymatic reaction between the hand-foot-and-mouth
virus protease, the recombinant
luciferase containing Gln-Gly and a test substance, detecting the
bioluminescence intensity of
fluorescein, thereby obtaining the hand-foot-and-mouth
disease resistant
drug activity of the test substance. The detection method disclosed by the invention has the advantages of simplicity, trace amount and rapidness, is small in
drug screening
workload, rapid and accurate in experiment and high in experimental result
repeatability and can be used for screening and developing hand-foot-and-mouth
disease resistant drugs. The method refers to a
bioluminescence detection method based on luciferase, the sensitivity is high, a few interference factors exist, and the compatibility of the test substance is high.